As for the specific effectiveness of each GLP1-RA, dulaglutide use could significantly decrease risks of both anxiety and depression, while liraglutide and exenatide showed no significant effect on reductions of either anxiety or depression. This evidence concerns the gene GLP1R and depressive disorder.